Viracta Therapeutics Stock (NASDAQ: VIRX) stock price, news, charts, stock research, profile.
You can purchase shares of Viracta Therapeutics (NASDAQ:VIRX) through any online brokerage.
There are no as such competitors for Viracta Therapeutics.
Viracta Therapeutics has a consensus price target of $5.04.
The stock price for Viracta Therapeutics (NASDAQ: VIRX) is $0.1526 last updated January 30, 2025 at 6:00 PM EST.
There are no upcoming dividends for Viracta Therapeutics.
Viracta Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
There is no upcoming split for Viracta Therapeutics.
Viracta Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.